synonym.bio

From Custom to Common: Standardising Project Development for Scalable Impact ⬇️ How can we reduce the costs of biomanufacturing? Check out this presentation from #BioInnovationsMidwest @SynonymBio #Biomanufacturing #ProjectDevelopment #ScaleImpact youtube.com/watch?v=V4g0yw…

Podcast 5YF#22 The $4T Bioeconomy, Nature’s Factory, AI Scientists, Global Bio Supremacy, and the Future of Biomanufacturing w/ @SynonymBio CEO @eshender podcasts.apple.com/au/podcast/24-…

Members ARCTOS, CleanJoule, Visolis, @Lygos_Inc and @SynonymBio have been awarded special funding from the @DeptofDefense to expand the domestic supply of ingredients and materials for U.S. supply chains by building bioproduction infrastructure: buff.ly/3LY6Fbe

Primient and @SynonymBio Forge Strategic Partnership to Propel U.S. #Bioproduct Innovation: The facility will offer services for companies utilizing precision #fermentation, enabling them to scale new product concepts from the lab to commercial production synbiobeta.com/read/primient-…

Navigating #Biomanufacturing's Biggest Challenge: The Scale-Cost Paradox. Joshua Lachter of @SynonymBio believes that in 2050, over 50% of the #petrochemicals we use in everyday life will be replaced with #bioproducts. Watch the video at synbiobeta.com/watch/the-scal… #energy #climate

Demand is solidifying for products that use biological processes and #GMOs in place of traditional product methods. But for change to happen, costs must come down. #Biomanufacturing has the potential to cut production costs by 50-90%. Learn more from our new report with @SynonymBio: on.bcg.com/3ImA9ha

👀 In a new report, @SynonymBio and The Boston Consulting Group (BCG) lays the roadmap for an imminent biomanufacturing moment! 👉 synonym.bio/synonym-bcg-re…

🛠 Biomanufacturing could potentially redefine how we produce everything, but it faces a major hurdle: infrastructure. @SynonymBio is here to help. I'm excited to share my Q&A with Joshua Lachter, co-founder of Synonym. A special thank you to Alex Jaffe for facilitating the Q&A!

Member @SynonymBio recently added Lifecycle Assessment (LCA) calculations to Scaler, its techno-economic analysis tool for the bioeconomy: buff.ly/425Vpkw

New feature alert! We just added Lifecycle Assessment (LCA) to Scaler, our TEA for the bioeconomy. Scaler LCA calculates the carbon intensity of bioproducts and provides users with improvement strategies. Get started for free today at scaler.bio.

Scale can transform the unit economics of #precisionfermentation, but it’s ‘not the most powerful lever,’ says @SynonymBio in a new report with an update on global #fermentation capacity. Via @AgFunder News: tinyurl.com/ppyxz2wd

Member @SynonymBio recently launched Scaler™, a free, next-gen techno-economic analysis (TEA) tool enabling companies using fermentation to project their costs of production and operations at commercial scale: scaler.bio

Introducing Scaler by @SynonymBio, our new techno-economic analysis tool for fermentation designed to empower companies in calculating commercial-scale production costs and accelerating their path to market. Check it out today at scaler.bio #precisionfermentation

Discover strategies to overcome the commercialization challenge with Joshua Lachter, CEO of @Synonymbio Join his roundtable session on 'Scale Fail? Finding the Capacity to Bring Bioproducts to Market' at @foodtechinvest summit on June 28. Register now: bit.ly/3UbHiWY

Learn more about what some of the SynBio Coalition members have been up to in the beginning of 2023: bit.ly/3ZAB7wG (bit.ly/3ZAB7wG) @AntheiaBio @Checkerspot_ @Genomatica @Ginkgo @SynonymBio

While the U.S. is a leader in biomanufacturing research, growth is dampened by the need for facilities. Our members @Genomatica, @Cargill, Fermworx, @danimersci, @manusbio, @SynonymBio & @LygosBiotech are leading the push for more infrastructure & capacity buff.ly/3LmY4zP

"The potential contribution of biomanufacturing to the economy is massive. Industry analysis suggests that bioengineering could account for more than 60% of the global output of manufacturing industries over the next few decades." More from @SynonymBio: buff.ly/3GGFyzS

2022 was a busy and productive year in the biomanufacturing world and we're excited for 2023! Despite this, we still made time for books, reports and podcasts. Here is our team's list of favorite biomanufacturing reads and listens of 2022: synonymbio.medium.com/we-love-learni…

Why were we so encouraged by the recent #PCAST report? The report underscores how critical #biomanufacturing is to the US and addresses many gaps @SynonymBio was born to fill. Read our full blog post 👉synonymbio.medium.com/bioeconomy-poi…

What's a theme that may be slightly overlooked in the climate venture capital space? @TommyStadlen (@giant_ventures) says it's #biomanufacturing and we couldn't agree more! 🏭 youtube.com/watch?v=ZwkK2C… #infrastructure #bioeconomy #synbio #alternativeproteins #biotech